RIGL
RIGEL PHARMACEUTICALS INC
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Gross Profit
$17.4M
↑ 7.9%
Operating Income
$125.5M
↑ 418.6%
Revenue
$294.3M
↑ 64.1%
Net Income
$367.0M
↑ 1999.1%
EPS (Diluted)
$19.48
↑ 1867.7%
Total Liabilities
$122.1M
↓ 24.0%
Total Assets
$513.6M
↑ 213.2%
Shareholders' Equity
$391.5M
↑ 11806.3%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 8/14/2026 View on SEC
SCHEDULE 13G/A 8/13/2026 View on SEC
S-8 8/4/2026 View on SEC
8-K 8/4/2026 View on SEC
10-Q 8/4/2026 View on SEC
4 7/10/2026 View on SEC
8-K 7/1/2026 View on SEC
4 6/24/2026 View on SEC
4 6/22/2026 View on SEC
4 6/22/2026 View on SEC

Company Information

Field Value
Ticker RIGL
Company Name RIGEL PHARMACEUTICALS INC
CIK 1034842
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 650-624-1100